D
TScan Therapeutics, Inc. TCRX
$1.82 $0.084.60% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -30.99% -35.83% -42.91% -26.01% -27.99%
Total Depreciation and Amortization -36.91% -30.96% -23.37% -15.96% -10.74%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 42.53% 52.64% 53.59% 3.76% 6.41%
Change in Net Operating Assets -104.57% -95.98% -71.29% -127.22% 372.41%
Cash from Operations -77.12% -77.72% -80.62% -99.95% 9.39%
Capital Expenditure -46.71% -54.40% -21.58% 15.98% -12.95%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 122.34% -240.29% 15.32% -24.32% --
Cash from Investing 112.11% -216.72% 13.41% -21.77% -1,765.12%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -94.64% -19.83% -18.75% -19.92% -22.76%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -77.07% 70.87% 71.44% 39.09% 39.24%
Cash from Financing -71.22% 53.26% 54.13% 20.34% -2.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -318.40% -69.72% 240.16% -223.46% -59.97%